Table 6.
Composition of formulations F1–F4 and C1–C6.
| Formulations | F1 | F2 | F3 | F4 | C1 | C2 | C3 | C4 | C5 | C6 |
|---|---|---|---|---|---|---|---|---|---|---|
| Drug (mg) | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 | 150 |
| P/K 7/3 | 75 | 150 | 75 | 150 | 75 | 112.5 | 150 | 75 | 112.5 | 150 |
| MCC PH102 | 37.5 | 75 | -- | -- | 37.5 | 56.3 | 75 | -- | -- | -- |
| HPCsslSPF | -- | -- | 37.5 | 75 | -- | -- | -- | 37.5 | 56.3 | 75 |
| Tablet (mg) | 262.5 | 375 | 262.5 | 375 | 262.5 | 318.8 | 375 | 262.5 | 318.8 | 375 |
| Hardness (kPa) | 4.37 | 8.47 | 5.2 | 13.56 | -- | -- | -- | -- | -- | -- |
| Floating | No | No | No | No | Yes | Yes | Yes | Yes | Yes | Yes |